Legal & General Group
SLS icon

Legal & General Group’s SELLAS Life Sciences SLS Stock Holding History

Legal & General Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.1K Buy
15,142
+2,110
+16% +$9.44K ﹤0.01% 2645
2025
Q4 		$49.1K Buy
13,032
+2,406
+23% +$4.68K ﹤0.01% 2730
2025
Q3 		$17.1K Hold
10,626
– – ﹤0.01% 3109
2025
Q2 		$23.3K Buy
+10,626
New +$16.3K ﹤0.01% 2947
2017
Q2 		– Sell
-1
Closed -$1K – 3378
2017
Q1 		$1K Hold
1
– – ﹤0.01% 3262
2016
Q4 		$2K Buy
+1
New +$5.82K ﹤0.01% 3282

Other funds holding SLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Legal & General Group's SLS Position: Q1 2026 in Review

Legal & General Group increased its SELLAS Life Sciences (SLS) stake by 16% in Q1 2026, buying an estimated $9.44K and bringing the position to 15,142 shares worth $64.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2645.

Legal & General Group first reported a position in SLS in Q4 2016 and has held it in 6 quarters since. 160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

  • Legal & General Group held 15,142 shares of SELLAS Life Sciences worth $64.1K as of Q1 2026.
  • Legal & General Group bought 2,110 SELLAS Life Sciences shares in Q1 2026, an estimated $9.44K.
  • SELLAS Life Sciences made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2645 holding.
  • Legal & General Group first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 6 quarters since.
  • 160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.